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Abstract
In vivo targeted gene disruption is a powerful tool to study gene function. Thus far, two tools
for genome editing in Aedes aegypti have been applied, zinc-finger nucleases (ZFN) and
transcription activator-like effector nucleases (TALEN). As a promising alternative to ZFN
and TALEN, which are difficult to produce and validate using standard molecular biological
techniques, the clustered regularly interspaced short palindromic repeats/CRISPR-
associated sequence 9 (CRISPR/Cas9) system has recently been discovered as a "do-it-
yourself" genome editing tool. Here, we describe the use of CRISPR/Cas9 in the mosquito
vector, Aedes aegypti. In a transgenic mosquito line expressing both Dsred and enhanced
cyan fluorescent protein (ECFP) from the eye tissue-specific 3xP3 promoter in separated
but tightly linked expression cassettes, we targeted the ECFP nucleotide sequence for dis-
ruption. When supplying the Cas9 enzyme and two sgRNAs targeting different regions of
the ECFP gene as in vitro transcribed mRNAs for germline transformation, we recovered
four different G1 pools (5.5% knockout efficiency) where individuals still expressed DsRed
but no longer ECFP. PCR amplification, cloning, and sequencing of PCR amplicons re-
vealed indels in the ECFP target gene ranging from 2-27 nucleotides. These results show
for the first time that CRISPR/Cas9 mediated gene editing is achievable in Ae. aegypti, pav-
ing the way for further functional genomics related studies in this mosquito species.
Introduction
The yellow fever mosquito, Aedes aegypti, is the principal vector for important arboviruses
such as yellow fever, dengue, and chikungunya viruses, which cause significant mortality and
morbidity among humans living in tropical regions of the world [1, 2]. Major research efforts
aim at understanding the genetics of vector competence for arboviruses in Ae. aegypti to ex-
plore novel ways to interrupt viral disease cycles [3]. Investigating the genetics of vector com-
petence relies on the study of gene function. An important aspect when studying gene function
is the ability to stably disrupt a gene-of-interest in a target-specific manner. Several targeted
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genome editing tools such as homologous recombination, zinc finger nucleases (ZFN) and
transcription activator-like effector nucleases (TALEN) have been extensively used for the
model insects Drosophila melanogaster and/or Bombyx mori [4–8]. Successful applications of
ZFN and TALEN have been also described for targeted genome editing in mosquitoes [9–13].
Both systems involve specifically tailored DNA binding proteins to introduce double-strand
breaks at the chosen target site of the host genome, leading to gene-knockout. ZFN and espe-
cially TALEN are highly effective; however, a major disadvantage is the fact that it is time-
consuming and complicated to engineer and validate target gene-specific ZFN or TALEN tools
in a standard laboratory. Consequently, most researchers purchase ZFN or TALEN reagents as
custom-made tools from specialized, commercial sources.
A promising novel alternative is the clustered regularly interspaced short palindromic
repeats/CRISPR-associated sequence 9 (CRISPR/Cas9) system, which has recently been discov-
ered as a true "do-it-yourself" genome editing tool. Similar to ZFN and TALEN, the CRISPR/
Cas9 system has been shown to be an efficient tool for genome editing in model organisms
such as nematode, Drosophila, zebrafish, rat, mouse, and also in B.mori [14–21]. CRISPR/Cas9
was discovered as a prokaryotic immunity-like system in bacteria and archaea [22–27]. Type II
CRISPR/Cas9 uses a CRISPR RNA (crRNA) and a transactivating RNA (tracrRNA) to guide
the Cas9 DNA endonuclease to induce site-specific dsDNA cleavage [28, 29]. Target specificity
of Cas9 is encoded by a 20-nucleotide (nt) spacer sequence in the crRNA, which pairs with the
tracrRNA to direct the endonuclease to the complementary target site in the genome [28]. In
Drosophila, a two-component system has been shown to be effective, in which crRNA and
tracrRNA are fused into a single RNA called synthetic guide RNA (sgRNA). An essential re-
quirement for efficient binding of the Cas9/sgRNA complex to the genomic target DNA is the
presence in the target sequence of a short protospacer adjacent motif (PAM) adjacent to the 20
nt spacer sequence. The PAM typically consists of the 3 nt motif NGG (with N being A, C, G,
or T) [29]. Thus, CRISPR/Cas9 based genome editing tools can be easily designed and generat-
ed, since a sgRNA with 20 nt target sequence identity adjacent to a 3 nt PAM is all that is need-
ed for recognition of the target DNA sequence. Cas9/sgRNA-mediated double-strand breakage
of the target DNA is recognized and repaired by the cellular DNA repair machinery via non-
homologous end joining (NHEJ) typically resulting in short nucleotide deletions or insertions
(indels), which disrupt the target gene.
As a proof-of-principle, we describe for the first time the use of CRISPR/Cas9 to stably dis-
rupt a gene-of-interest in the mosquito vector, Ae. aegypti. We tested different CRISPR/Cas9
constructs with the aim to disrupt the coding sequence of the enhanced cyan fluorescent
protein (ECFP) gene in a transgenic mosquito line, which expresses both ECFP and Dsred
from the eye-specific 3xP3 promoter. Successful disruption of the marker gene demonstrated
that the CRISPR/Cas9 system is a functional tool for targeted gene disruption in Ae. aegypti, al-
though we found that the overall efficiency of the system appears to be lower in this insect spe-
cies than what has been reported for Drosophila or B.mori.
Materials and Methods
Mosquitoes
Ae. aegypti recipients for CRISPR/Cas9-mediated gene disruption were hybrids resulting from
a cross between the Higgs white eye strain (HWE) [30] and transgenic line PubB2 P61 [31, 32].
PubB2 P61 mosquitoes harbor two piggyBac transposable element (TE) integrations. Each
copy of the piggyBac transgene contains two separate fluorescent eye marker expression cas-
settes, DsRed and ECFP, each under control of the 3xP3 promoter (Fig. 1). Both eye marker ex-
pression cassettes are physically closely linked based on PhiC31-mediated recombination, in
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which ECFP originates from docking strain attP26 and DsRed from the attB-site containing
donor plasmid. To maintain the transgenic line in a double-hemizygous state, inbred PUbB2
P61 mosquitoes were outcrossed to the non-transgenic HWE recipient strain.
Plasmid constructs
Plasmid phsp70-Cas9 containing the coding sequence (CDS) of Cas9 was obtained from
Addgene (https://www.addgene.org/45945) [33]. Two different Cas9 expression vectors were
derived from this plasmid: PUb/Cas9/SV40A and hsp70/Cas9/SV40A. To create PUb/Cas9/
SV40A, the Cas9 CDS of phsp70-Cas9 was inserted into pSLfa1180fa-PUb/SV40A [32] using
restriction enzymes NotI and NheI. Therefore the Cas9 CDS was PCR-amplified using a
forward primer containing the NotI site and a reverse primer containing the NheI site. PCR
amplification was conducted using AccuPrime proof-read polymerase (Invitrogen, Life Tech-
nologies, Carlsbad CA). Plasmid hsp70/Cas9/SV40A was generated by exchanging the hsp70
3’UTR for the SV40A polyadenylation sequence using restriction enzymes XbaI and BamHI.
As described above, matching restriction sites were added to the cDNA insert via proof-read
polymerase PCR.
DrU6.sgRNA constructs were based on pU6-BbsI-chiRNA, which was obtained from
Addgene (https://www.addgene.org/45946). ECFP-targeting, guide sequence containing cDNAs
were inserted into plasmid DrU6.sgRNA via BbsI restriction sites. For each guide sequence, a
separate Ae. aegyptiU6 promoter (AeU6).sgRNA construct was generated as a custom-made
cDNAmolecule (IDT-DNA, Coralville, IA), which was then inserted into pSLfa11280fa using
SacI and SmaI. The nucleotide sequence of the Ae. aegyptiU6 promoter (AeU6) is: 5’-GAAT
GAAATCGCCCATCGAGTTGATACGTCCATCCATCGCTAGAACCGCGTTCGCTGTA
GAAGACTATATAAGAGCAGAGGCAAGAGTAGTGAAAT-3’ [34].
ECFP-targeting guide sequences were based on the ECFP CDS (GenBank accession:
KJ081792.1) and identified using the ZiFiT Targeter Version 4.2 design tool (http://zifit.
partners.org/ZiFiT). Suggested guide sequences were validated for unique target specificity by
blasting against the Ae. aegypti genome (AaegL.3.2.) (https://www.vectorbase.org/organisms/
aedes-aegypti). Two guide RNA sequences were chosen: sg13 5’-GCGCGATCACATGG
TCCTGC-3’ and sg35 5’-GCACTGCACGCCCCAGGTCA-3’. sg13 targeted ECFP between
Fig 1. Schematic representation of the transgene in Ae. aegypti line PUbB2 P61 and the ECFP gene depicting sg35 and sg13 target sites. A single
copy of the transgene is shown. The protospacer adjacent motifs (PAM) are indicated in red. Abbreviations: pB left, pB right = piggyBac transposon left or
right arm; svA = SV40 polyA signal; ECFP = cyan fluorescent protein gene; 3xP3 = eye-specific synthetic promoter; attR, attL = right or left PhiC31
attachment site; DsRed = red fluorescent protein gene; v5B2 = Flockhouse virus B2 gene; PUb = Ae. aegypti poly-ubiquitin promoter.
doi:10.1371/journal.pone.0122353.g001
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nucleotide positions 645–664 of the sense strand (with TGG as PAMmotif) and sg35 targeted
ECFP between nucleotide positions 213–194 of the antisense strand (with GGG as PAMmotif)
(Fig. 1; S1A Fig).
Expressing Cas9 and chimeric RNAs from in vitro transcribed RNAs
For Cas9 mRNA in vitro transcription, plasmid MLM3613 was obtained from Addgene
(https://www.addgene.org/42251) and was linearized using PmeI. Linearized plasmid was in
vitro transcribed using mMESSAGE mMACHINE T7 ULTRA kit (Ambion, Life Technologies)
following the protocol of the manufacturer. After transcription, a poly(A) tail was added to the
3’ end of the capped mRNA using the Poly(A) Tailing Kit (Ambion, Life Technologies). The
Cas9 mRNA was purified with MEGAclear Transcription Clean-Up Kit (Ambion, Life Tech-
nologies). As template for guide RNA expression from the T7 RNA promoter, plasmid DR274
was obtained from Addgene (https://www.addgene.org/42250). ECFP targeting guide se-
quences 13sgRNA and 35sgRNA were inserted into DR274 as described above. sgRNAs were
in vitro transcribed from the DraI-digested sgRNA expression vectors using the MAXIscript
T7 in vitro Transcription Kit (Ambion, Life Technologies). Resulting sgRNAs were purified
with MEGAclear Transcription Clean-Up Kit (Ambion, Life Technologies).
Microinjections, outcrossing, pooling of mosquitoes
Purified Cas9 mRNA and each sgRNA, 13sgRNA and 35sgRNA, were mixed to final concen-
trations of 1 μg/μl and 50 ng/μl respectively, prior to injection into PUbB2 P61 x HWE hybrid
embryos. Cas9-expressing plasmid DNA and sgRNA encoding plasmids were injected at final
concentrations of 500 ng/μl and 150 ng/μl, respectively. The following combinations were set
up: RNA: T7/Cas9+T7 sg13+T7 sg35; DNA1: PUb/Cas9+Ae(des)U6 sg13+AeU6 sg35; DNA2:
hsp70/Cas9+AeU6 sg13+AeU6 sg35; DNA3: PUb/Cas9+Dm(Drosophila)U6 sg13+DmU6
sg35; DNA4: hsp70/Cas9+DmU6 sg13+DmU6 sg35 (Fig. 2).
Plasmid DNAs were diluted in 2X microinjection buffer [5 mM KCl, 0.1 mMNaH2PO4
(pH 6.8)] [35]. Embryo microinjections were performed as previously described [32, 35, 36].
Five days post-injection, eggs were hatched and survival rates recorded (Table 1). Adult G0
were visually screened for loss of eye-specific ECFP expression under a Leica M10 stereomicro-
scope equipped with a fluorescent light source and specific filter sets. Surviving G0 males were
singly outcrossed to 15 HWE females and surviving G0 females were pooled in groups of 4 to
14 and outcrossed to three HWE males each. Following a 2-day mating period, crosses based
on G0 males were pooled in groups of two to three in order to reduce the number of required
bloodfeeds. A few of the RNA-injected G0 individuals were not pooled following outcrossing to
HWEmales; instead they were maintained as families (a single injected G0 founder x HWE).
Mosquitoes were artificially bloodfed with defibrinated sheep blood (Colorado Serum Co, Den-
ver, CO) as described [31, 36]. At least two eggliners were produced from each pool/family.
DNA Sequencing of genomic regions targeted by CRISPR/Cas9
Each target locus of the ECFP gene was PCR-amplified from genomic DNA of individual
adults (G0) or pools of 5 to 20 G1 or G2 larvae. PCR products were either sequenced directly or
cloned into a plasmid vector using the pCR4-TOPO TA cloning kit (Invitrogen, Life Technolo-
gies) prior to sequencing. From each Escherichia coli transformation, at least 10 colonies were
picked and prepared for sequencing at the University of Missouri DNA Core. Mutated alleles
were identified by sequence comparison with the original ECFP nucleotide sequence.
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Results
Embryo microinjection and survival rates
Numbers of microinjected eggs for each CRISPR/Cas9 construct ranged from 529 (DNA3) to
685 (DNA1) (Table 1). Survival rates were lowest for DNA2 (4.5%) and highest for RNA
(11.7%). With the exception of the RNA-injected eggs where only 1/3 of the survivors were fe-
male, sex ratios were balanced in the other treatments. Only three out of 23 RNA injected mos-
quito pools and one family (based on a single female G0 founder) produced G1 individuals
showing ECFP knockout. Assuming that in each of the four pools only a single G0 individual
was mutant (see below), we estimated a target gene knockout efficiency of 5.5%.
Visual screening for ECFP knockout phenotypes
None of the RNA- or DNA-injected G0 survivors showed loss of eye-specific ECFP expression.
Three pools of the RNA-injected mosquitoes, P41, P49, P55, and one family, F82, generated G1
Table 1. Transformation data of PUbB2 P61 x HWE embryos injected with different CRISPR/Cas9 constructs
RNA DNA1 DNA2 DNA3 DNA4
No. of embryos injected 626 685 602 529 605
No. of G0 survivors 27♀, 46♂ 36♀, 38♂ 14♀, 13♂ 39♀, 35♂ 34♀, 36♂
No. of pools 7♀, 16♂ 5♀, 16♂ 1♀, 5♂ 4♀, 11♂ 3♀, 12♂
No. of G1 KO pools 2♀, 2♂ 0 0 0 0
Estimated KO efﬁciency 5.5%
KO: knockout.
doi:10.1371/journal.pone.0122353.t001
Fig 2. Flowchart showing generation and identification of ECFP knockout mutants based on transgenic PUbB2 P61 x HWE hybrids. Five groups of
Cas9/sgRNA constructs were each micro-injected into ~500–700 double-hemizygous embryos (G0). All surviving G0 individuals were outcrossed to HWE
and pooled. All G1 individuals of each pool were screened for the ECFP knockout phenotype. Pools containing individuals with ECFP knockout phenotype
were again outcrossed to HWE to generate G2. DNA was extracted and sequenced from G0 adults and from G1 and G2 larvae showing ECFP knockout
phenotype and also from groups of G1 larvae, which did not show a mutant phenotype.
doi:10.1371/journal.pone.0122353.g002
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larvae amongst which eye-specific ECFP expression was no longer visible, even though these
larvae strongly expressed DsRed. These phenotypes were maintained in eyes of adults (Fig. 3).
However, we did not detect any G1 larvae with ECFP knockout phenotype among those pools
injected with DNA1, DNA2, DNA3, or DNA4.
The presence of an ECFP knockout phenotype in double-hemizygous G1 and its absence
among double- hemizygous G0 individuals supports the conclusion that in G0 only one ECFP
allele was disrupted by CRISPR/Cas9. This conclusion is further supported by the segregation
patterns among G1 of pools P41, P49, P55, and family F82, which all contained individuals
with ECFP phenotypes (Table 2).
Fig 3. Eyemarker expression in PUbB2 P61 x HWEmosquitoes before and after CRISPR/Cas9mediated ECFP knockout. Eyes were viewed under a
fluorescent stereo microscope (Leica M205) equipped with DsRed (A, C, E) or ECFP (B, D, F) specific filter sets. (A, B) Eyes of a PUbB2 P61 x HWE female.
(C, D) Eyes of a (PUbB2 P61 x HWE) P41 female (G1) originating from an embryo which had been injected with in vitro transcribed RNAs encoding Cas9 and
two ECFP targeting sgRNAs, sg13 and sg35. (E, F) Eyes of a HWE female. (G) Eyes of the HWE female under bright field.
doi:10.1371/journal.pone.0122353.g003
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Around 53% of the G1 PUbB2 P61 x HWE hybrids arising from the first parental bloodfeed-
ing were non-transgenic, which follows the expected segregation pattern considering the trans-
gene-associated fluorescent eye markers being dominant traits. Interestingly, the average
proportion of non-transgenic progeny arising from the second parental bloodfeeding was only
42%. Proportions of G1 larvae showing knockout of ECFP varied between 5 and 46% (from
first parental bloodmeal) and 8 and 52% (from second parental bloodmeal). Extreme observa-
tions were F82 with only a single female G0 founder and P49 based on three male G0 founders,
in which<10% and>90%, respectively, of the transgenic G1 individuals had an ECFP knock-
out phenotype. Similar to the other pools, all G1 siblings of P49 showed a uniform indel variant.
Thus, it is unlikely that more than one male founder of P49 carried the ECFP
knockout genotype.
Outcrossing of the G1 mutants to HWE showed that the ECFP knockout mutations were
stably inherited in the following generation. The proportion of individuals exhibiting the mu-
tant phenotype amounted to around 50% in outcrossed G2 of P41, P49, P55, and F82 (Table 2).
Genotypic analysis of ECFP knockout mosquitoes
In pools P41, P49, and P55, CRISPR/Cas9 mediated targeting of the genome by sg35 resulted
in a deletion of two nucleotides within the CDS of ECFP leading to a frameshift mutation with-
in the gene (Fig. 4). In P49 and P55, both having an identical indel variant, two nucleotides
were deleted 3 nt downstream of the PAM sequence, which is considered the typical cleavage
site of Cas9 [28]. In P41, the deletion occurred 1 nt downstream of the PAM sequence. In F82,
a 27 nt deletion adjacent to the PAM sequence resulting from sg35-mediated CRISPR/Cas9 ge-
nome targeting translated into the loss of the peptide LTWGVQCFS from the predicted ECFP
protein. In the highly similar enhanced green fluorescent protein, the tripeptide T66Y67G68
(LTYGVQCFS) is essential for forming the p-hydro-xybenzylidene-imidazolinone (HBI) chro-
mophore within the central helix that runs through the center of the capped beta-barrel struc-
ture of the protein [37]. In general, cleavage patterns and size ranges of CRISPR/
Table 2. Proportion of different eye marker phenotypes among G1 and G2 larvae of pools P41, P49, P55, and family F82.
Phenotype Pool 41 3♂×40 HWE♀ Pool 49 3♂×40 HWE♀ Pool 55 9♀×21 HWE♂ Family 82 1♀×3 HWE♂
G1 progeny resulting from 1. bloodfeed of G0 hybrids*
Dsred positive, ECFP positive 190 13 131 28
DsRed positive, ECFP negative 70 (13%) 158 (46%) 0 3 (5%)
DsRed negative, ECFP negative 294 (53%) 169 (50%) 161 (55%) 35 (53%)
Total 554 340 292 66
G1 progeny resulting from 2. bloodfeed of G0 hybrids*
Dsred positive, ECFP positive 170 11 247 33
DsRed positive, ECFP negative 42 (10%) 89 (52%) 37 (8%) 9 (17%)
DsRed negative, ECFP negative 190 (47%) 72 (42%) 175 (38%) 20 (38%)
Total 402 172 459 52
Outcrossed G2 progeny**
Dsred positive, ECFP positive 0 0 0 0
DsRed positive, ECFP negative 284 (50%) 325 (47%) 290 (49%) 54 (50%)
DsRed negative, ECFP negative 286 (50%) 363 (53%) 296 (51%) 53 (50%)
Total 570 688 586 107
*PUBB2 P61 x HWE embryos (G0) were injected with CRISPR/Cas9 RNA constructs.
**G2 mutants x HWE.
doi:10.1371/journal.pone.0122353.t002
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Cas9-mediated indels in the genomic DNA of Ae. aegypti were not fundamentally different
from those observed in the genomes of Drosophila or B.mori [38–42]. In the outcrossed G2,
the same indels were detected for P41, P49, P55, and F82 indicating that those knockout muta-
tions were stable and heritable (data not shown).
Interestingly, only sg35 but not sg13 enabled ECFP-specific dsDNA cleavage even though
both sgRNAs were selected using the same ZiFiT algorithm. Previously, it had been revealed
that the efficiency of a sgRNA to bind to its target correlated with the GC content in its se-
quence 6 nt adjacent to its PAM [16]. However, both sgRNAs, sg13 and sg35, had the same
level of GC content (67%) in their respective 6 nt sequences near the PAM. For sg35 no se-
quence similarity was detected in the genome of Ae. aegypti whereas for sg13, 14 of 20 nucleo-
tides of the 5’ region of the sgRNA were identical to the CDS of gene AAEL007920 (though an
adjacent PAMmotif was absent in the gene sequence) (S1B Fig).
Sequencing of DNA fragments spanning the sgRNA target sites from 15 (out of 23) G0 indi-
viduals originating from the RNA injected embryos (Table 1) did not result in the detection of
indels. Also, no indels were revealed when sequencing DNAs from G1 larvae (~20 larvae/sample)
Fig 4. CRISPR/Cas9mediated indels in the ECFP gene of PUBB2 P61 x HWE hybrids. (A) Sanger-sequencing trace data showing the regions of the
indels in mutants P41, P49, P55, and F82. Arrows indicate the cleavage site; the sequence of guide RNA sg35 is shadowed. (B) Nucleotide sequence
alignments showing indels. The ECFP nucleotide sequence is shown at the top with the sg35 target site in bold-type and the PAM sequence in red. Deletions
are shown as dashes. cDNA fragments spanning each target site were PCR-amplified using genomic DNA from pooled larvae as template and cloned into
the pCR4-TOPO TA vector. At least 10 cDNA clones per PCR amplicon were sequenced.
doi:10.1371/journal.pone.0122353.g004
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of 13 different pools including P41, P49, P55, and F82, which originated from RNA injected G0
embryos and expressed both eye markers (Fig. 2).
Discussion
We targeted the eye marker gene ECFP in a double-hemizygous transgenic Ae. aegypti hybrid,
PUbB2 P61 x HWE, expressing both DsRed and ECFP from the eye-specific 3xP3 promoter.
Successful knockout of ECFP was predicted to result in individuals that express only the DsRed
marker. Two sgRNA sequences were designed with the intention to cleave the ECFP gene si-
multaneously at two sites, separated by 470 bp, to obtain a truncated ECFP gene in the mutated
progeny. According to reports from the literature, we tested several construct designs to identi-
fy a procedure that yielded maximal efficiency in Ae. aegypti. Using the two-plasmid compo-
nent system for germline-specific expression of Cas9 (non-codon optimized for Ae. aegypti)
and sgRNAs, construct designs included the AePUb or Drosophila hsp70 promoters driving ex-
pression of Cas9 and AeU6 or Drosophila U6 promoters for sgRNA expression. Alternatively,
we transformed embryos with separate in vitro transcribed mRNAs encoding Cas9 and the two
sgRNAs [15, 38]. Interestingly, only the in vitro transcribed mRNAs resulted in the generation
of ECFP knockout mutants. We think that the failure of the plasmid DNA constructs to gener-
ate ECFP knockout mutants could be due to two major reasons. First, the plasmid DNA sys-
tems may have had too low efficiencies in Ae. aegypti compared to B.mori or Drosophila so
that a number of 500–700 injected embryos was generally too low to recover mutants. Alterna-
tively, the promoters of the constructs may not have driven high enough expression of the
CRISPR/Cas9 system in Ae. aegypti. However, in conjunction with applications other than
CRISPR/Cas9, both Drosophila hsp70 and AePUb promoters have been shown to efficiently
drive gene expression in Ae. aegypti embryos [9, 35, 36], making this an unlikely possibility.
We only tested a single AeU6 promoter in our assay, which had been characterized and suc-
cessfully used in an earlier study [34]. It is possible that this promoter might not be the optimal
choice for the CRISPR/Cas9 system. Likewise, the Drosophila U6 promoter might not be func-
tional in the mosquito germline.
In Drosophila, the yellow gene was knocked out with a germline mutation rate of up to 6%
when using a two-plasmid component system in which Cas9 was expressed from the Drosophi-
la hsp70 promoter and a single sgRNA from Drosophila U6 [33, 39]. The germline mutation
rate based on yellowmosaic phenotypes observed among the injected G0 increased to 66%
(n = 52) when 2 sgRNAs were used to delete the coding sequence of yellow instead of a single
sgRNA disrupting the gene at a single locus. Germline mutation rates in B.mori ranged be-
tween 17 and 30% when using plasmid DNAs to express Cas9 and sgRNAs from B.mori-
specific promoters. The variation in mutation efficiency was strongly affected by the sequence
of each of the three different sgRNAs, which were used to disrupt the BmKu70 gene [40]. An-
other report using the CRISPR/Cas9 system in B.mori showed a mutation frequency of 15% in
the kynu-2 locus of B.mori embryos injected with plasmids expressing Cas9 and a single
sgRNA [41].
When using in vitro transcribed mRNAs of Cas9 and sgRNAs, we obtained a germline mu-
tation rate of 5.5%. This is in stark contrast to observations with Drosophila where knockout
mutation rates reached 86% in G0 when expressing Cas9 and sgRNAs from in vitro transcribed
mRNAs [15]. Bassett and colleagues [15] showed that reducing Cas9 mRNA concentrations in
their embryo injection experiments while keeping sgRNA concentrations (50 ng/μl) constant,
reduced the proportion of G0 Drosophila with mosaic phenotype from 86% (1 μg/μl Cas9
RNA) to 10% (0.13 μg/μl Cas9 RNA). In our experimental set-up with Ae. aegypti, we applied
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Cas9 mRNA and sgRNAs at concentrations of 1 μg/μl and 50 ng/μl, respectively, which in Dro-
sophila led to a maximal mutation rate.
Contrary to the findings described above, we were not able to discover ECFP mosaic pheno-
types among the G0 of Ae. aegypti. However, outcrossing to the non-transgenic HWE recipient
strain resulted in G1 that produced the ECFP knockout phenotype (Table 2, Fig. 3). As stated
above, we think that only one of two ECFP gene alleles was disrupted among G0 individuals of
pools P41, P49, P55, and family F82. Thus, the dominant intact ECFP allele would produce an
intact fluorescent blue-eye phenotype, which then would overshadow any mosaic expression
pattern in the same tissue. We maintained the CRISPR/Cas9 recipient mosquito strain, PUbB2
P61 x HWE, in a hemizygous state because we were aware that this transgenic line harbors two
transgene copies and we could not predict how efficiently the genome editing tool would target
both alleles simultaneously instead of one. However, due to segregation of the G1, we could eas-
ily identify ECFP knockout mutants, which were stably maintained in outcrossed G2.
We designed two sgRNAs, 470 bp apart from each other, to delete a major portion of the
ECFP gene. Surprisingly, sgRNA13 did not seem to bind to its target site to promote dsDNA
breakage followed by NHEJ. Both sgRNAs were designed to recognize the same target gene,
had similar GC contents and secondary structures and were selected by the same ZiFiT algo-
rithm. Thus, it is unclear why sg13 was not functional. Other researchers have also noticed that
various sgRNAs can differ substantially in their dsDNA cleavage efficiency [15, 16, 33]. Wei
and colleagues [42] speculated that potential secondary structures or sequence motifs in
sgRNA sequences may account for different target site recognition efficiencies, but these are
still not well understood. Our observation could be an indication that sgRNAs may function
less efficiently in the complex genomic environment of Ae. aegypti than in the condensed ge-
nome structure of Drosophila. Our results also indicate that more than one or two sgRNA se-
quences for each DNA target in Ae. aegyptimay need to be tested. Thus, a multiplex gene
targeting approach as successfully applied in Drosophila and B.mori to target several genes si-
multaneously or to delete larger fragments of genomic DNAmay be more difficult to design
for Ae. aegypti [17, 33, 41].
Conclusions and Future Directions
We tested the efficacy of the CRISPR/Cas9 system in a transgenic mosquito line expressing two
different eye markers, which allowed us to take advantage of a simple visual screening system
for knockout mutants (presence of DsRed expression in absence of ECFP expression). Use of a
rapid visual screening system was of great importance, because it was not foreseeable whether
our CRISPR/Cas9 constructs would be functional in Ae. aegypti and if so, how efficient they
would be. Since our transgenic line had two transgene copies, it complicated the screening pro-
cess because mosaic-type mutants could not be identified among the G0 as may have been more
likely in presence of a single transgene copy. Regardless, line PUbB2 P61 was the most suitable
mosquito line we had available for this proof-of-principle study. Our study clearly demonstrates
that CRISPR/Cas9-mediated gene editing is achievable in Ae. aegypti. Several observations sug-
gest that the anticipated ease-of-use of the CRISPR/Cas9 systemmay be less efficient in this in-
sect species: i) only one of two sgRNAs designed to target the same marker gene was functional
indicating that it might be more difficult to predict successful sgRNA designs for use in Ae.
aegypti; ii) only the in vitro transcribed mRNA Cas9 and sgRNA constructs, and not those
based on expression plasmids enabled genome targeting and dsDNA cleavage in Ae. aegypti; iii)
when using in vitro transcribed Cas9 mRNA and sgRNAs, mutation rates in Ae. aegypti were
substantially lower than those observed inDrosophila and B.mori. However, it needs to be em-
phasized that these observations need further validation in subsequent experiments.
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Future refinements aimed at enhancing Cas9/sgRNA expression levels and efficiencies
could include the generation of transgenic driver strains of Ae. aegypti that would express the
Cas9 gene in the germline from the Ae-nanos promoter, similar to proven strategies for Dro-
sophila [16, 43–45]. Further, bicistronic expression of Cas9 and sgRNA from the same plasmid
vector [46], or development of a tissue-specific CRISPR/Cas9-mediated conditional mutagene-
sis system by combining CRISPR/Cas9 with the UAS-Gal4 system [47] could potentially im-
prove the efficacy of the CRISPR/Cas9 system in Ae. aegypti.
An important and novel application of the CRISPR/Cas9 system in Ae. aegypti would be the
targeted disruption of an endogenous gene-of-interest in combination with knock-in of a se-
lectable marker gene via homologous recombination. In view of such an experiment, we are
now confident that in vitro transcribed mRNA-based CRISPR/Cas9 constructs are functional
in Ae. aegypti.
Supporting Information
S1 Fig. (A) Sequence alignments of guide RNAs sg35 (blue/bold) and sg13 (burgundy/bold)
with the nucleotide sequences of the fluorescent reporter genes ECFP, EGFP (enhanced green
fluorescent protein), and DsRed. Nucleotide mismatches are shown in red. (B) Alignment of
guide RNA sg13 with endogenous gene AAEL007920 of Ae. aegypti. Location where a hypo-
thetical PAM sequence should be present is highlighted in blue. Nucleotide mismatches are
shown in red.
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